Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

COVID vaccines for children under 5 possible by June 21, White House says

The FDA and CDC will still need to authorize the shots.

Axios

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Americans may soon get a new COVID-19 vaccine option — a more traditional kind of shot known as a protein vaccine

The Independent UK

Covid vaccines for the under-fives - what parents need to know

Children under five represent the only age group yet to have a vaccine approved for use

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Accepts Myovant Sciences and Pfizer's Filing For Review In Uterine Fibroids

Myovant Sciences (NASDAQ: MYOV) and Pfizer (NASDAQ: PFE) received U.S.

Benzinga

Why The FDA Isn't The Battleground For Pfizer's, Moderna's Pediatric Covid Shots

The youngest Americans could soon be inoculated against Covid, but whether uptake will help stoke vaccine stocks remains to be seen.

Investors Business Daily

Pfizer Seeks FDA Approval For Three Covid Vaccine Doses For Children Below Five

Partners Pfizer, Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) urged the FDA to authorize three vaccine doses for children below five, the Wall Street Journal reports. The companies previously asserted that three doses of the shot were 80% effective at preventing symptomatic Covid-19 with robust immune response in children between six months to five years. After mixed results…

Benzinga

‘We’re playing with fire’: US COVID cases may be 30 times higher than reported

Severe undercounting undermines our efforts to ‘understand and get ahead of the virus’, researcher says after New York survey

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Pfizer submits COVID-19 shot for children under 5 for FDA authorization

WASHINGTON — Pfizer Inc. asked U.S. regulators to clear its COVID-19 vaccine for emergency use in children under age 5, an effort to extend protection against the virus to the country’s youngest.

Tribune News Service

COVID vaccines for children under five: what parents need to know

Pfizer’s COVID-19 vaccine became available for children aged five to 11 in the UK in April 2022. Those aged 12 and up had already been eligible since 2021.

The Conversation

GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, June 1

Reuters Redbird Capital Buys Italian Football Club AC Milan

Benzinga

Oil Stocks Lead Charge Of Breakouts And Buy Zones In New Uptrend

With a new uptrend underway, oil stocks like TotalEnergies and tech stocks like Synopsys set the stage for new breakouts.

Investors Business Daily

Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off

Pfizer Inc. (NYSE:PFE) intends to sell its 32% investment in Haleon, a consumer health joint venture with GSK plc (NYSE:GSK), after the business is spun out as an independent listed company in July, reported Reuters. Pfizer had previously indicated that it might seek to sell its stake in Haleon, a consumer health company and…

Benzinga

Stock Market Today - 6/1: Stocks End Lower As Inflation Worries Linger; Fed Begins Balance Sheet Sales

Stocks finished lower Wednesday as investors enter June in much the same way they exited May: worried about inflation and eyeing central bank reactions.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Stocks Edge Higher, Fed, Salesforce, Pfizer And Elon Musk - 5 Things You Must Know

Stock futures edge higher, but inflation worries linger; Fed begins 'quantitative tightening' with balance sheet run-off; Salesforce shares leap after Q1 earning beat, profit forecast boost; Pfizer to exit consumer healthcare JV with GlaxoSmithKline and Elon Musk weighs-in on work-from-home

Investors Business Daily

GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck

GlaxoSmithKline announced Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close.

Reuters

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

Daily Mirror

Man died of 'catastrophic' Covid jab reaction after outdated advice from vaccine hub

Jack Hurn became unwell with "castatrophic" blood clots eight days after receiving the AstraZeneca vaccine despite having been reassured by staff that it would be safe for him

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The New Daily

Planning a holiday? What’s the COVID situation in Bali, Fiji, NZ and the UK?

Here are a few general tips for a safer and enjoyable holiday, and a quick look at the COVID situation in four popular holiday destinations.

The Conversation

Planning a holiday? What's the COVID situation in Bali, Fiji, NZ and the UK?

Many of us are considering a long-delayed overseas trip. However, despite what our politicians are telling us, the pandemic is not over yet, and there is always the risk you could catch COVID on holiday or just before you depart.

Daily Record

Spain's Covid booster jab entry requirement for all holidaymakers explained

Tourists going to Spain might need to prepare a more thorough proof of vaccination.

Benzinga

Pfizer's Combo Therapy For Fatty Liver Disease Gets FDA Fast Track Status

The U.S. Food and Drug Administration has granted Fast Track designation to Pfizer’s (NYSE: PFE) Ervogastat/Clesacostat Combination therapy for the treatment of Non-Alcoholic Steatohepatitis (NASH).

Benzinga

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Conversation

How important is the COVID-19 booster shot for 5-to-11-year-olds? 5 questions answered

COVID-19 case numbers are rising again in the U.S. – including among children. In mid-May 2022, the Food and Drug Administration authorized a booster shot of the COVID-19 vaccine for U.S. children ages 5 to 11, and the Centers for Disease Control and Prevention followed by recommending a booster shot…

1 … 48 49 50 51

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations